ArticleAnnals of medicine and surgery (2012)2026
FDA approval of mirdametinib for NF1-associated plexiform neurofibromas: clinical and regulatory perspectives.
Mahnoor Sheikh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it